DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS

Vision - Provide all Warriors affected by orthopaedic injuries sustained in the defense of our Constitution the opportunity for optimal recovery and restoration of function

Peer Reviewed Orthopaedic Research Program Cover Image
» Click on Image to View Program Booklet

PRORP Strategic Plan Image
» Click on Image to View Strategic Plan

A large majority of the injuries sustained by military personnel in U.S. combat efforts involve soft tissue wounds and skeletal fractures, pointing to an urgent need for orthopaedic research that will provide superior medical care and treatment options for injured Service members. Orthopaedic injuries sustained during combat-related activities tend to be heterogeneous and complex in nature, typically involving multiple tissues, such as skin, bone, muscle, cartilage, and nerves. These injuries are sustained in harsh environments where access to optimal acute care can be limited, and they are distinct from those seen in the civilian setting, frequently involving multiple limb trauma, open fractures, major tissue loss, and a high degree of wound contamination. The Department of Defense Peer Reviewed Orthopaedic Research Program (PRORP) was established by Congress in fiscal year 2009 (FY09) to support military-relevant, peer-reviewed orthopaedic research with potential to provide healthcare solutions for the injured Service member, Veteran, and civilian.


Congressional Appropriations

Congressional Appropriations

  • $368.5 million
    FY09-FY18
  • $30 million
    FY19

Related Videos

CAPT Eric Hofmeister, MD (USN, Ret.)

Synergy Specialist Medical Group
Focusing on Optimal Recovery and Restoration for our Servicemembers

news_icon News & Highlights

Vision

Provide all Warriors affected by orthopaedic injuries sustained in the defense of our Constitution the opportunity for optimal recovery and restoration of function

Mission

Address the most significant gaps in care for the leading burden of injury and for facilitating return-to-duty by funding innovative, high-impact, clinically relevant research to advance optimal treatment and rehabilitation from musculoskeletal injuries sustained during combat and combat-related activities

Last updated Wednesday, September 18, 2019